Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Tempest Therapeutics, Inc. | mlnd-20191231xex321.htm |
| EX-31.2 - EX-31.2 - Tempest Therapeutics, Inc. | mlnd-20191231xex312.htm |
| EX-31.1 - EX-31.1 - Tempest Therapeutics, Inc. | mlnd-20191231xex311.htm |
| EX-23.1 - EX-23.1 - Tempest Therapeutics, Inc. | mlnd-20191231xex231.htm |
| EX-10.43 - EX-10.43 - Tempest Therapeutics, Inc. | mlnd-201912x31xex1043.htm |
| EX-10.29 - EX-10.29 - Tempest Therapeutics, Inc. | mlnd-20191231xex1029.htm |
| EX-10.17 - EX-10.17 - Tempest Therapeutics, Inc. | mlnd-201912x31xex1017.htm |
| EX-10.16 - EX-10.16 - Tempest Therapeutics, Inc. | mlnd-20191231xex1016.htm |
| EX-10.8 - EX-10.8 - Tempest Therapeutics, Inc. | mlnd-20191231xex108.htm |
| EX-4.6 - EX-4.6 - Tempest Therapeutics, Inc. | mlnd-20191231xex46.htm |
| 10-K - 10-K - Tempest Therapeutics, Inc. | mlnd-20191231.htm |
Exhibit 21.1
| Name of Subsidiary | Jurisdiction of Organization | ||||
| Millendo Therapeutics SAS | France | ||||
| Millendo Therapeutics US, Inc. | Delaware | ||||
| Millendo Therapeutics Ltd | London, England | ||||
| OvaScience Securities Corporation | Massachusetts | ||||
| OvaScience Bermuda Limited | Hamilton, Bermuda | ||||
| OvaScience Limited | London, England | ||||